PCRX icon

Pacira BioSciences
PCRX

Overview Fund Activity

260 hedge funds and large institutions have $3.01B invested in Pacira BioSciences in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 105 increasing their positions, 84 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
260
Holders Change
+3
Holders Change %
+1.17%
% of All Funds
4.61%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
29
Increased
105
Reduced
84
Closed
23
Calls
$10.1M
Puts
$8.96M
Net Calls
+$1.18M
Net Calls Change
+$5.36M

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$83.7M
2
BlackRock
2
BlackRock
New York
$425M
3
Macquarie Group
3
Macquarie Group
Australia
$165M
4
Loomis, Sayles & Company
4
Loomis, Sayles & Company
Massachusetts
$67.9M
5
Canada Pension Plan Investment Board
5
Canada Pension Plan Investment Board
Ontario, Canada
$13.9M

Top Sellers

1
LCG
1
Lisanti Capital Growth
New York
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$157M
3
DM
3
Deerfield Management
New York
$62.8M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$3K
5
Man Group
5
Man Group
United Kingdom
$4.53M
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
276
TwinBeech Capital
New York
– -$213K -3,539 Closed
AS
277
Altshuler Shaham
Israel
– -$25K -424 Closed
CAL
278
Capital Analysts LLC
Pennsylvania
– -$6K -100 Closed
AII
279
AGF Investments Inc
Ontario, Canada
– -$3K -45 Closed
ASN
280
Advisory Services Network
Georgia
– -$2K -40 Closed
BWA
281
BDO Wealth Advisors
Florida
– -$1K -9 Closed
8 9 10 11
12